NCT01433666View on ClinicalTrials.gov

Roflumilast and Cognition

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2013

Conditions
Dementia
Interventions
DRUG

roflumilast (EU: Daxas, USA: Daliresp)

Acute intervention: 1 time each dose on different days. Capsulated

DRUG

Placebo

Acute intervention: single administration, capsulated form.

DRUG

roflumilast

Acute intervention: 1 time each dose (100ug, 300ug, 1000ug, placebo). Capsulated.

Trial Locations (1)

6200 MD

Maastricht University, Faculty of Psychology and Neuroscience, Maastricht

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Maastricht University Medical Center

OTHER

NCT01433666 - Roflumilast and Cognition | Biotech Hunter | Biotech Hunter